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presented with cardiovascular deterioration after 
2 weeks of septicemia with critical decompensa‑
tion, an incident of cardiopulmonary resuscita‑
tion, and a full spectrum of multiorgan failure. 
Huge antibiotic ‑resistant vegetations protrud‑
ing into the mitral valve orifice was confirmed 
by echocardiography.
The second patient, a 15‑month ‑old boy with 
a body weight of 8 kg and a history of misdiag‑
nosed aortic coarctation, after late aortic arch re‑
pair at the age of 5 months, initially with left ven‑
tricular failure (LVF), and significant MVI. The boy 
was readmitted to the department because of sep‑
sis and cardiopulmonary deterioration due to mi‑
tral AE with positive microbiological tests.
Both children were referred after the progres‑
sion of congestive HF due to massive MVI and 
LVF. The girl was treated for pulmonary edema 
with mechanical ventilation, inotropic support, 
and high ‑dose diuretics. The second patient had 
circulatory instability and multiorgan deterio‑
ration despite advanced medical therapy, pre‑
sented with shortness of breath and peripheral 
hypoperfusion. In both patients, transthoracic 
echocardiography (TTE) showed massive MVI 
with fixed vegetations over the posterior and an‑
terior leaflets, disrupted anterior chordae, left 
atrial enlargement, and severe LVF. The first 
blood cultures were all negative and the second, 
incidentally positive (Staphylococcus warneri in 
2 separate blood cultures, additional coloniza‑
tion of Klebsiella pneumoniae).
After 2 weeks of preoperative antibiotic ther‑
apy, the children were referred for life ‑saving 
Introduction Acute endocarditis (AE) is a rare 
disease in children, presenting with aggressive 
septic destruction of endocardial structures and 
consecutive acute heart failure (HF) that neces‑
sitates pediatric heart valve surgery in emergen‑
cy settings.1,2 Irreparable valves are a challenge, 
with a number of limitations related to the lack 
of prostheses commercially designed for valve 
replacements in children.
The Melody transcatheter pulmonary valve 
(Medtronic BV, Heerlen, the  Netherlands), 
a stented bovine jugular vein graft, was intro‑
duced for percutaneous implantation in the pul‑
monary position. Acceptable midterm results 
were achieved for the alternative implantation 
technique of mitral valve replacement (MVR) in 
children.3,4 The advantages of the Melody valve 
are perfect hemodynamics with favorable effec‑
tive orifice area index, low transannular gradi‑
ent, intraoperative annular adjustment hybrid 
strategy, and most importantly, a unique poten‑
tial for minimally invasive percutaneous balloon 
dilation following expected growth of the child.5
We present a brief report of 2 consecutive pe‑
diatric emergency MVRs with the expendable 
Melody bioprosthesis in a single cardiothorac‑
ic surgery center.
Methods The first patient, a 23‑month ‑old 
girl with a body weight of 12 kg was referred 
for surgery due to HF with critical mitral valve 
incompetence (MVI) proven by echocardiogra‑
phy and cardiogenic shock. The girl, a premature 
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Both procedures were performed with extra‑
corporeal circulation, mild hypothermia, and 
aortic cross ‑clamp. The mitral valve was exposed 
via classic transseptal approach. The vegetations 
of both mitral leaflets were found and dissect‑
ed. Complete damage of leaflets and chordae was 
observed. After the gentle resection of vegeta‑
tions, a small rim of leaflets was left over the an‑
nulus to avoid injury to conduction and coro‑
nary systems during implantation. Hegar dila‑
tors (14 × 16 × 18 mm) were used for initial siz‑
ing of the annulus with subsequent local povi‑
done‑iodine flush.
The Melody valve prostheses were compressed 
and crimped to allow the  passage through 
the mitral annulus (FIGURE 1C). The sewing ePTFE 
ring of the valves was secured to the mitral an‑
nulus with 3 semicontinuous sutures, and final‑
ly tied immediately after the initial balloon dila‑
tation. Finally, the balloon dilation of the valves 
was performed with the Tyshak II balloon cath‑
eter 16 mm / 30 mm (NuMED Inc, Hopkinton, 
surgical mitral repair or replacement procedures 
in emergency settings.
Both 18‑mm Melody valves were prepared 
just before the  operations. To enable surgi‑
cal implantation, sewing cuffs (3‑mm stripes 
of expanded polytetrafluoroethylene [ePTFE], 
incised every 10 mm; Gore ‑Tex, W. L. Gore 
& Associates Inc., Flagstaff, Arizona, United 
States) were added externally to the midsec‑
tion of the stents. The stripes were attached to 
the stents with interrupted superficial sutures 
and shallow bites limited to anchor the metal 
elements. The first Melody valve was prepared 
with excision of its apical part to avoid any in‑
terference with the left ventricular outflow tract 
(FIGURE 1A). The second Melody valve was double‑
‑folded: both ends of the stent were folded out‑
side to shorten the valve and facilitate the im‑
plantation in the mitral orifice (FIGURE 1B). In the 
first patient only, the posterior pap illary mus‑
cle was fixed with secured sutures and the stent 
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although there is still a limited number of re‑
ports on the Melody valves implanted in pa‑
tients with AE.
The decision to use the Melody valves in 2 con‑
secutive children with AE were made based on 
a strong belief that stented bioprostheses may 
prove more effective than any other artificial 
valves in the septic environment. The risk of en‑
docarditis associated with the Melody valves was 
previously reported and analyzed in prostheses 
implanted in the right ventricular outflow tract 
and in vitro studies. The risk of infection and 
damage to the Melody valve exposed to bacte‑
ria is similar as in other biological valves and im‑
planted homografts.7,8 In line with surgical prin‑
ciples, all potentially dangerous infected tissues 
were carefully excised and flushed with povidone‑
iodine before the implantation of the Melody 
prostheses. The mitral implantation technique 
with the use of semi continuous sutures derives 
from the personal experience of the surgeons.
Conclusions Melody MVR appeared to be a safe 
and effective treatment for pediatric patients 
with AE. The acute phase of mitral valve endo‑
carditis was not a contraindication for primary 
Melody MVR procedures. The Melody valve may 
be a good solution for the treatment of severe de‑
struction of the mitral valve in children, taking 
into account the small size of the native mitral 
ring and the potential for child growth. In this 
context, it is important to know the technique 
of valve preparation that ensures its safe surgi‑
cal implantation.
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New York, United States) at a pressure of 4 to 
6 atm. The balloon sizes were calculated fol‑
lowing preoperative measurements of the an‑
nular size by echocardiogram and intraopera‑
tive Hegar dilator. After dilatation, the valves 
were inspected to ensure free mobility of all 
3 leaflets of the prosthesis. In the first patient, 
the atrial side of the stent was flared to limit 
the valve protrusion into the left left atrial cav‑
ity, while the second valve was initially double‑
‑folded to limit the valvular length. The atrial 
septal closures with the calibrated ePTFE patch 
were performed. The epicardial echocardiogra‑
phy and TTE (Philips Epiq 7, Philips Healthcare, 
Best, the Netherlands) at discharge in both pa‑
tients confirmed good function of the Melody 
valves without any signs of left ventricular out‑
flow tract obstruction (FIGURE 1D). Heparin was in‑
troduced as postoperative anticoagulation and 
switched to long ‑term oral aspirin treatment.
Antibiotics were continued up to 6 weeks in ac‑
cordance with the European Society of Cardiolo‑
gy guidelines for the treatment of bacterial endo‑
carditis. Our first patient was discharged home 
after 4 weeks and the second patient, after 6 
weeks; both with negative blood cultures and in‑
flammatory parameters within the normal range.
Short‑ and midterm postoperative follow ‑up 
TTEs (2 vs 36 months) showed sustained good 
competence of the Melody valves. Both chil‑
dren returned back to their normal life activities.
Results and discussion Surgical treatment 
in children with AE is still rare; nevertheless, 
there are some studies reporting successful mi‑
tral valve repairs in young children. The authors 
described mitral valve repair in infants with en‑
docarditis and concluded that mitral valve re‑
construction should be the therapy of choice in 
bacterial endocarditis, particularly in children 
and adolescents.1
There are promising reports of successful Mel‑
ody MVR procedures in children based on multi‑
center data.4 Although they only include reports 
on midterm results, there are some significant ar‑
guments for the utility of stented expandable bio‑
prosteses for MVRs in small children. They pres‑
ent valid concerns with regard to the length of the 
Melody valve and the lack of a standard sewing 
cuff to anchor the device to the atrioventricular 
annulus.6 Therefore, the presented modifications 
of the valve stents with additionally sewed cuffs 
and specific implantation techniques are neces‑
sary to allow implantation, provide stable posi‑
tion in the mitral annulus, and avoid left ventric‑
ular outflow tract obstruction.5 In the presented 
cases, the preparation of the Melody valves was 
performed before the initiation of the procedure 
in order to limit the extracorporeal circulation 
and cross ‑clamp times.
The reports on the Melody MVR confirmed 
good function at short‑ and midterm follow ‑up, 
